A randomized phase II preoperative study of autophagy inhibition with high-dose hydroxychloroquine and gemcitabine/nab-paclitaxel in pancreatic cancer patients

HJ Zeh, N Bahary, BA Boone, AD Singhi… - Clinical cancer …, 2020 - AACR
Purpose: We hypothesized that autophagy inhibition would increase response to
chemotherapy in the preoperative setting for patients with pancreatic adenocarcinoma. We …

A Randomized Phase II Preoperative Study of Autophagy Inhibition with High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic Cancer …

HJ Zeh, N Bahary, BA Boone, AD Singhi… - Clinical Cancer …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Purpose:</jats: title>< jats: p> We
hypothesized that autophagy inhibition would increase response to chemotherapy in the …

A Randomized Phase II Preoperative Study of Autophagy Inhibition with High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic Cancer …

HJ Zeh, N Bahary, BA Boone… - … : an official journal …, 2020 - pubmed.ncbi.nlm.nih.gov
Purpose We hypothesized that autophagy inhibition would increase response to
chemotherapy in the preoperative setting for patients with pancreatic adenocarcinoma. We …

[PDF][PDF] A Randomized Phase II Preoperative Study of Autophagy Inhibition With High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic Cancer …

DP Normolle, AH Zureikat, ME Hogg, DL Bartlett, K Lee… - academia.edu
Purpose: We hypothesized that autophagy inhibition would increase response to
chemotherapy in the preoperative setting for patients with pancreatic adenocarcinoma. We …

A randomized phase II preoperative study of autophagy inhibition with high-dose hydroxychloroquine and gemcitabine/nab-paclitaxel in pancreatic cancer patients

HJ Zeh, N Bahary, BA Boone… - Clinical Cancer …, 2020 - ohiostate.elsevierpure.com
Purpose: We hypothesized that autophagy inhibition would increase response to
chemotherapy in the preoperative setting for patients with pancreatic adenocarcinoma. We …

[PDF][PDF] A Randomized Phase II Preoperative Study of Autophagy Inhibition With High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic Cancer …

DP Normolle, AH Zureikat, ME Hogg, DL Bartlett, K Lee… - medicine.hsc.wvu.edu
Purpose: We hypothesized that autophagy inhibition would increase response to
chemotherapy in the preoperative setting for patients with pancreatic adenocarcinoma. We …

[HTML][HTML] A Randomized Phase II Preoperative Study of Autophagy Inhibition With High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic …

H Zeh, N Bahary, BA Boone, AD Singhi… - … cancer research: an …, 2020 - ncbi.nlm.nih.gov
Purpose: We hypothesized that autophagy inhibition would increase response to
chemotherapy in the preoperative setting for patients with pancreatic adenocarcinoma. We …

[PDF][PDF] A Randomized Phase II Preoperative Study of Autophagy Inhibition With High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic Cancer …

DP Normolle, AH Zureikat, ME Hogg, DL Bartlett, K Lee… - medicine.wvu.edu
Purpose: We hypothesized that autophagy inhibition would increase response to
chemotherapy in the preoperative setting for patients with pancreatic adenocarcinoma. We …

A randomized phase II preoperative study of autophagy inhibition with high-dose hydroxychloroquine and gemcitabine/nab-paclitaxel in pancreatic cancer patients

HJ Zeh, N Bahary, BA Boone… - Clinical Cancer …, 2020 - utsouthwestern.elsevierpure.com
Purpose: We hypothesized that autophagy inhibition would increase response to
chemotherapy in the preoperative setting for patients with pancreatic adenocarcinoma. We …

A Randomized Phase II Preoperative Study of Autophagy Inhibition with High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic Cancer …

HJ Zeh, N Bahary, BA Boone, AD Singhi… - … Cancer Research: an …, 2020 - europepmc.org
Purpose We hypothesized that autophagy inhibition would increase response to
chemotherapy in the preoperative setting for patients with pancreatic adenocarcinoma. We …